Romaguera, J. E., Fayad, L., Rodriguez, M. A., Broglio, K. R., Hagemeister, F. B., Pro, B., . . . Cabanillas, F. F. (2005). High rate of durable remissions after treatment of newly diagnosed aggressive mantle-cell lymphoma with rituximab plus hyper-CVAD alternating with rituximab plus high-dose methotrexate and cytarabine. Journal of clinical oncology, 23(28), 7013. https://doi.org/10.1200/JCO.2005.01.1825
Chicago-Zitierstil (17. Ausg.)Romaguera, Jorge E., et al. "High Rate of Durable Remissions After Treatment of Newly Diagnosed Aggressive Mantle-cell Lymphoma with Rituximab Plus Hyper-CVAD Alternating with Rituximab Plus High-dose Methotrexate and Cytarabine." Journal of Clinical Oncology 23, no. 28 (2005): 7013. https://doi.org/10.1200/JCO.2005.01.1825.
MLA-Zitierstil (9. Ausg.)Romaguera, Jorge E., et al. "High Rate of Durable Remissions After Treatment of Newly Diagnosed Aggressive Mantle-cell Lymphoma with Rituximab Plus Hyper-CVAD Alternating with Rituximab Plus High-dose Methotrexate and Cytarabine." Journal of Clinical Oncology, vol. 23, no. 28, 2005, p. 7013, https://doi.org/10.1200/JCO.2005.01.1825.